Skip links

Haegarda® [C1 esterase inhibitor subcutaneous (human)]

Full Name Haegarda® [C1 esterase inhibitor subcutaneous (human)]
Drug Haegarda
Manufacturer CSL Behring
Route of Administration Subcutaneous
Site of Care Home
Approved Indication Routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form
Phone Number 800-356-4252
Fax Number 847-631-6918
Product Website haegarda.com/hcp